Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$1.13M Buy
8,527
+349
+4% +$46.9K 0.16% 252
2017
Q2
$1.09M Buy
8,178
+756
+10% +$102K 0.16% 263
2017
Q1
$1M Buy
7,422
+6,263
+540% +$811K 0.2% 204
2016
Q4
$139K Sell
1,159
-5,496
-83% -$648K 0.03% 506
2016
Q3
$833K Sell
6,655
-662
-9% -$86.7K 0.17% 241
2016
Q2
$1.01M Sell
7,317
-3,652
-33% -$474K 0.24% 141
2016
Q1
$1.38M Buy
10,969
+4,952
+82% +$629K 0.36% 57
2015
Q4
$763K Buy
6,017
+3,508
+140% +$435K 0.22% 186
2015
Q3
$290K Sell
2,509
-32,101
-93% -$3.6M 0.07% 454
2015
Q2
$3.6M Buy
34,610
+2,833
+9% +$306K 0.46% 70
2015
Q1
$3.51M Buy
31,777
+25,739
+426% +$2.79M 0.48% 63
2014
Q4
$629K Buy
+6,038
New +$604K 0.13% 258

Other funds holding CLX

GAM Systematic's CLX Position: Q3 2017 in Review

GAM Systematic increased its Clorox (CLX) stake by 4.3% in Q3 2017, buying an estimated $46.9K and bringing the position to 8,527 shares worth $1.13M. The position accounts for 0.16% of the portfolio, ranked #252.

GAM Systematic first reported a position in CLX in Q4 2014 and has held it in 12 quarters since. The position peaked at $3.6M in Q2 2015. 857 funds tracked by Wall St. Rank hold CLX as of Q3 2017.

  • GAM Systematic held 8,527 shares of Clorox worth $1.13M as of Q3 2017.
  • GAM Systematic bought 349 Clorox shares in Q3 2017, an estimated $46.9K.
  • Clorox made up 0.16% of GAM Systematic's portfolio in Q3 2017, its #252 holding.
  • GAM Systematic first reported a position in Clorox in Q4 2014 and has held it in 12 quarters since.
  • GAM Systematic's Clorox position peaked at $3.6M in Q2 2015.
  • 857 funds tracked by Wall St. Rank held Clorox as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.